• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者权益倡导组织。

Advocacy groups for breast cancer patients.

作者信息

Waller M, Batt S

机构信息

Department of Anthropology and Sociology, John Abbott College, Sainte-Anne-de-Bellevue, Que.

出版信息

CMAJ. 1995 Mar 15;152(6):829-33.

PMID:7697576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1337756/
Abstract

Breast cancer patient advocacy groups emerged in the 1990s to support and empower women with breast cancer. Women with cancer and oncologists tend to have divergent perspectives on how breast cancer prevention should be defined and what the priorities for research should be. As their American counterparts have done, breast cancer patient advocates in Canada are seeking greater participation in decision making with respect to research. To date they have had more input into research policy decisions than into the planning of specific projects. In 1993 the National Forum on Breast Cancer recommended that women with breast cancer should have more input into the research process; breast cancer patient advocates will continue to actively pursue this objective.

摘要

乳腺癌患者权益倡导组织于20世纪90年代出现,旨在支持患乳腺癌的女性并赋予她们力量。癌症患者和肿瘤学家对于乳腺癌预防应如何定义以及研究重点应该是什么往往有不同的观点。和美国同行一样,加拿大的乳腺癌患者倡导者正在寻求更多地参与研究决策。迄今为止,他们在研究政策决策方面的投入比在具体项目规划方面的投入更多。1993年,全国乳腺癌论坛建议乳腺癌患者应更多地参与研究过程;乳腺癌患者倡导者将继续积极追求这一目标。

相似文献

1
Advocacy groups for breast cancer patients.乳腺癌患者权益倡导组织。
CMAJ. 1995 Mar 15;152(6):829-33.
2
Health professional and consumer views on involving breast cancer patients in the multidisciplinary discussion of their disease and treatment plan.医疗专业人员和消费者对于让乳腺癌患者参与其疾病及治疗方案多学科讨论的看法。
Cancer. 2007 Nov 1;110(9):1937-44. doi: 10.1002/cncr.23007.
3
Experiences of breast cancer survivor-advocates and advocates in countries with limited resources: a shared journey in breast cancer advocacy.乳腺癌幸存者倡导者以及资源有限国家倡导者的经历:乳腺癌倡导中的共同历程
Breast J. 2006 Jan-Feb;12 Suppl 1:S111-6. doi: 10.1111/j.1075-122X.2006.00208.x.
4
Backing and forthing: the process of decision making by women considering participation in a breast cancer prevention trial.反复权衡:女性考虑参与乳腺癌预防试验的决策过程。
Oncol Nurs Forum. 2001 May;28(4):703-9.
5
Attitudes of Canadian oncology practitioners toward psychosocial interventions in clinical and research settings in women with breast cancer.加拿大肿瘤学从业者对乳腺癌女性临床及研究环境中社会心理干预措施的态度。
Psychooncology. 1997 Sep;6(3):178-89. doi: 10.1002/(SICI)1099-1611(199709)6:3<178::AID-PON271>3.0.CO;2-O.
6
Addressing the support needs of women at high risk for breast cancer: evidence-based care by advanced practice nurses.满足乳腺癌高危女性的支持需求:高级执业护士提供的循证护理。
Oncol Nurs Forum. 2002 Jul;29(6):E77-84. doi: 10.1188/02.ONF.E77-E84.
7
The experience of making treatment decisions for women with early stage breast cancer: a diagrammatic representation.为早期乳腺癌女性患者做出治疗决策的经验:一种图表呈现方式。
Eur J Cancer Care (Engl). 2005 Jul;14(3):249-55. doi: 10.1111/j.1365-2354.2005.00565.x.
8
The decision-making experience among women diagnosed with stage I and II breast cancer.
Breast Cancer Res Treat. 2007 Mar;102(1):51-9. doi: 10.1007/s10549-006-9309-6. Epub 2006 Jul 19.
9
Cognitive and affective determinants of decisions to attend a group psychosocial support program for women with breast cancer.乳腺癌女性参加团体心理社会支持项目决策的认知和情感决定因素。
Psychosom Med. 2005 Jul-Aug;67(4):584-9. doi: 10.1097/01.psy.0000170834.54970.f5.
10
Policy and advocacy in the quest for effective translational breast care research.追求有效的转化型乳腺癌护理研究中的政策与倡导。
Breast. 2010 Aug;19(4):303-6. doi: 10.1016/j.breast.2010.03.011. Epub 2010 Apr 15.

引用本文的文献

1
Terri Coutee: ASPS Patient of Courage, 2018.特里·库蒂:2018年美国整形外科学会勇敢患者。
Plast Reconstr Surg Glob Open. 2019 Oct 29;7(10):e2451. doi: 10.1097/GOX.0000000000002451. eCollection 2019 Oct.
2
Patient organizations in Finland: increasing numbers and great variation.芬兰的患者组织:数量不断增加,差异巨大。
Health Expect. 2010 Sep;13(3):221-33. doi: 10.1111/j.1369-7625.2008.00499.x. Epub 2010 Jun 23.
3
Investments in cancer genomics: who benefits and who decides.癌症基因组学投资:谁受益,谁决策。
Am J Public Health. 2006 Nov;96(11):1960-4. doi: 10.2105/AJPH.2005.075424. Epub 2006 Oct 3.

本文引用的文献

1
Sex steroids and breast cancer prevention.性类固醇与乳腺癌预防。
J Natl Cancer Inst Monogr. 1994(16):139-47.
2
Empowerment and persons with cancer: politics in cancer medicine.赋权与癌症患者:癌症医学中的政治学
J Palliat Care. 1990 Summer;6(2):33-45.
3
Persons with cancer speak out: reflections on an important trend in Canadian health care.
J Palliat Care. 1992 Winter;8(4):30-7.
4
Ethics in aboriginal research. A model for minorities or for all?原住民研究中的伦理。一种适用于少数群体还是所有人的模式?
Med J Aust. 1992 Oct 19;157(8):553-5.
5
Tamoxifen: disease prevention or disease substitution?
Lancet. 1992 Nov 7;340(8828):1143-5. doi: 10.1016/0140-6736(92)93161-f.